Home | Welcome to Contract Pharma   
Last Updated Saturday, November 22 2014
Print

Breaking News

Related Searches:
April 27, 2011
MPI Research has acquired and implemented a Gyrolab xP workstation from Gyros AB into its time-critical project workflows.   Read More »
April 26, 2011
Pharmaceutics International Inc. (Pii) has added an MG2G140 capsule filler to its solid oral GMP manufacturing area, expanding its existing commercial manufacturing capabilities.  Read More »
April 26, 2011
Pharmacyclics, Inc. has received a $7 million milestone payment from Les Laboratoires Servier (Servier) for its histone deacetylase (HDAC) inhibitor, PCI-24781 / S 78454.   Read More »
April 26, 2011
Manuela Leone has been appointed president of contract research services (CRS) for Harlan Laboratories, Inc.  Read More »
April 26, 2011
Louis Fries III, M.D., has been appointed vice president, clinical and medical affairs, and Jane Halpern, Ph.D., has been appointed vice president of regulatory affairs at Novavax, Inc.   Read More »
April 25, 2011
Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities with the purchase of a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.  Read More »
April 25, 2011
Sanofi Pasteur received approval from the FDA for the expanded use of meningococcal conjugate vaccine Menactra in infants and children 9 to 23 months of age.  Read More »
April 25, 2011
OncoMed Pharmaceuticals and Bayer HealthCare have expanded their collaboration under which Bayer will manufacture clinical supplies of a second Wnt inhibitor.  Read More »
April 25, 2011
GVK Biosciences has extended its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the FDA.   Read More »
April 25, 2011
Bernhard Hampl, Ph.D., has been appointed co-chairman of Cytovance Biologics, Inc.   Read More »
April 21, 2011
U.S. product sales in the quarter increased 4% to $2.8 billion.  Read More »
April 21, 2011
Growth in the quarter was primarily driven by Tysabri revenues, up 15% to $251 million, and Avonex sales, up 8% to $642 million.   Read More »
April 21, 2011
Sales of Atripla were up 7% to $744.5 million. Sales of Truvada were up 2% to $673.1 million.   Read More »
April 21, 2011
Gross business wins in the quarter were $329 million, representing a book to bill of 1.43.  Read More »
April 21, 2011
ICON and ACRONET Corp. have signed an alliance agreement under which the two companies will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities to manage trials both regionally and globally.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On